CONTACT
+91 80 2808 2808
info@biocon.com

News - Posts

Biocon  /  News – Posts

Biocon Q4FY22 Revenue at Rs 2,476 Cr, Up 21%; Core EBITDA at Rs 815 Cr, Up 37% ; PBT(before Exceptional Items) at Rs 384 Cr, Up 9%
  • Thu, 28-Apr-2022
  • Posted by: BIOCON
No Comments

NeoBiocon Partners with Novartis to offer Vildagliptin for Diabetics in UAE
  • Thu, 28-Apr-2022
  • Posted by: BIOCON
No Comments

Biocon Biologics’ Insugen® Awarded a Three-Year Contract by Ministry of Health, Malaysia
  • Tue, 26-Apr-2022
  • Posted by: BIOCON
No Comments

Biocon Biologics’ Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion
  • Fri, 01-Apr-2022
  • Posted by: BIOCON
No Comments

University of Glasgow Names their Flagship Research Centre After John Shaw and Kiran Mazumdar-Shaw
  • Tue, 29-Mar-2022
  • Posted by: BIOCON
No Comments

Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society of Edinburgh (RSE)

Kiran Mazumdar-Shaw Elected as the Fellow of Royal Society
  • Wed, 23-Mar-2022
  • Posted by: BIOCON
No Comments

HPRA Completes Audit of Biocon Biologics New mAbs Drug Substance Facility in Bengaluru
  • Thu, 03-Mar-2022
  • Posted by: BIOCON
No Comments

Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
  • Mon, 28-Feb-2022
  • Posted by: BIOCON
No Comments

Biocon Q3FY22 Revenue at Rs 2,223 Cr, Up 18%; EBITDA at Rs 537 Cr, Up 25%; Biosimilars Up 28% at Rs 981 Cr; Research Services Up 10% at Rs 641 Cr; Generics Up 7% at Rs 607 Cr
  • Thu, 20-Jan-2022
  • Posted by: BIOCON
No Comments

The USFDA issues a complete response letter for the Biologics License Application (BLA) for insulin Aspart
  • Fri, 07-Jan-2022
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>